Search

Displaying results 7171 - 7180 of 7657 in total
  1. Drug

    Daidzein

    go.drugbank.com/drugs/DB13182
    Investigational

    Categories: Estrogens, Non-Steroidal
  2. Drug

    Eltoprazine

    go.drugbank.com/drugs/DB12883
    Investigational

    Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  3. Drug

    Ramiprilat

    go.drugbank.com/drugs/DB14208
    Experimental

    The active metabolite of the prodrug Ramipril.

    Categories: Agents Acting on the Renin-Angiotensin System
  4. Drug

    Gepefrine

    go.drugbank.com/drugs/DB13703
    Experimental

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  5. Drug

    Bardoxolone

    go.drugbank.com/drugs/DB12651
    Investigational

    Bardoxolone has been used in trials studying the treatment of LYMPHOMA and Solid Tumors. It is a synthetic triterpenoid and a highly potent activator of redox-sensitive signaling pathways that induce programmed cell death (apoptosis) in ...

  6. Drug

    Mepindolol

    go.drugbank.com/drugs/DB13530
    Investigational

    Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.

    Categories: Beta Blocking Agents, Non-Selective
  7. Drug

    N-(carboxycarbonyl)-D-phenylalanine

    go.drugbank.com/drugs/DB08263
    Experimental

    N-(carboxycarbonyl)-D-phenylalanine is a solid. This compound belongs to the n-acyl-alpha amino acids.

    Synonyms: N-(carboxycarbonyl)-D-phenylalanine
  8. Drug

    6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine

    go.drugbank.com/drugs/DB08099
    Experimental

    This compound belongs to the phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group. This substance targets the protein renin.

  9. Drug

    Furvina

    go.drugbank.com/drugs/DB16547
    Experimental

    It is used to treat dermatological infections.[A228063]

  10. Drug

    Allovectin-7

    go.drugbank.com/drugs/DB17439
    Investigational

    It was discontinued after it failed to improve the objective response rate or overall survival versus first-line chemotherapy in malignant melanoma.[A255207]